Our study identified that CNE2 cells contain a small population of CD133+ cells with a strong potential for self-renewal, proliferation and differentiation, suggesting that CD133 represents a marker of NPC stem cells. The gene discussed is PROM1; the disease is nasopharyngeal carcinoma.